Allergy review series VI: The immunology of fetuses and infants. Immune responses during allergic sensitization and the development of atopy

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 55, Issue 11, 2000, Pages 989-997

  Savelkoul, H F J ^a   Neijens, H J ^b  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b SOPHIA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; ALLERGEN;

ALLERGIC DISEASE; ATOPY; CYTOKINE PRODUCTION; ENVIRONMENTAL EXPOSURE; FETUS; HEREDITY; HUMAN; IMMUNE RESPONSE; INFANT; POLYCLONAL ACTIVATION; PRIORITY JOURNAL; REVIEW; SENSITIZATION; T LYMPHOCYTE; BIOSYNTHESIS; CHILD; FEMALE; HYPERSENSITIVITY; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; PREGNANCY; RISK FACTOR;

ALLERGENS; CHILD; CYTOKINES; FEMALE; FETUS; HUMANS; HYPERSENSITIVITY; LYMPHOCYTE ACTIVATION; PREGNANCY; RISK FACTORS; T-LYMPHOCYTES;

EID: 0034328022     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1398-9995.2000.00124.x     Document Type: Review

References (85)

1. Cellular and molecular mechanisms for reduced interleukin-4 and interferon-γ production by neonatal T cells
2. Defective IFN-γ production in the human neonate
3. Cytokine regulation of immunoglobulin secretion by neonatal lymphocytes
4. Impaired production of γ-interferon by newborn cells in vitro is due to a functionally immature macrophage
5. Development of long-term tolerance versus sensitisation to environmental allergens during the perinatal period
6. TH2-polarized immunological memory to inhalant allergens in atopics is established during infancy and early childhood
7. Allergen- and bacterial antigen-specific T-cell clones established from atopic donors show a different profile of cytokine production
8. T cell subsets and cytokines in allergic and non-allergic children. I. Analysis of IL-4, IFN-γ and IL-13 mRNA expression and protein production
9. T cell subsets and cytokines in allergic and non-allergic children. II. Analysis of IL-5 and IL-10 mRNA expression and protein production
10. The role of IL-13 in IgE synthesis by allergic asthma patients
11. Transplacental priming of the human immune system to environmental allergens: Universal skewing of initial T-cell responses toward the Th2 cytokine profile
12. Reduced interferon gamma production by antigen-stimulated cord blood mononuclear cells is a risk factor of allergic disorders - 6-year follow-up study
13. Reduced interferon-γ secretion in neonates and subsequent atopy
14. Food hypersensitivity and atopic dermatitis: Evaluation of 113 patients
15. Atopic dermatitis: Clinical relevance of food hypersensitivity reactions
16. Atopic dermatitis in early infancy predicts allergic airway disease at 5 years
17. Risk factors in early childhood for the development of atopic diseases
18. The prevalence of and risk for atopy in early childhood: A whole population birth cohort study
19. The effect of genetic and environmental factors on the prevalence of allergic disorders at the age of two years
20. The development of allergy in high-risk children
21. Parental smoking and allergic sensitisation in children
22. Passive smoking as a risk factor for development of obstructive respiratory disease and allergic sensitization
23. Maternal smoking during pregnancy and lactation increases the risk for atopic eczema in the offspring
24. Increased incidence of asthma in children of smoking mothers
25. Effect of pre- and post-natal tobacco smoke exposure on specific sensitization to food and inhalant allergens during the first 3 years of life
26. The environment and sensitisation to allergens in early childhood
27. Effect of active and passive smoking during pregnancy on natural killer-cell activity in infants
28. Indoor allergen exposure is a risk factor for sensitization during the first three years of life
29. Peripheral blood mononuclear cell proliferative responses in the first year of life in babies born to allergic parents
30. Is deficiency of interferon gamma production by allergen triggered cord blood cells a predictor of atopic eczema?
31. Mode of delivery directs the phagocyte functions of infants for the first 6 months of life
32. Leukocyte counts in relation to the method of delivery during the first five days of life
33. Development of allergen-specific T-cell memory in atopic and normal children
34. Decreased production of IFN-γ and increased production of IL-6 by cord blood mononuclear cells of newborns with a high risk of allergy
35. Interferon-γ production by cord-blood mononuclear cells is reduced in newborns with a family history of atopic disease and is independent from cord blood IgE-levels
36. Detection of specific polymerase chain reaction product by utilizing the 5'-3' exonuclease activity of Thermus aquaticus DNA polymerase
37. The predictive relationship between serum IgE levels at birth and subsequent incidences of lower respiratory illnesses and eczema in infants
38. Predictive values of cord blood IgE and cord blood lymphocyte responses to food antigens in allergic disorders during infancy
39. Reciprocal age-related patterns of allergen-specific T-cell immunity in normal vs atopic infants
40. Synthesis of T helper 2-type cytokines at the maternal-fetal interface
41. Bidirectional cytokine interactions in the maternal-fetal relationship: Is successful pregnancy a Th2 phenomenon?
42. Studies of human cord blood dendritic cells: Evidence for functional immaturity
43. Functional and phenotypic differences of monocyte-derived dendritic cells from allergic and nonallergic patients
44. The paradigm of type 1 and type 2 antigenpresenting cells. Implications for atopic allergy
45. + T-cell subsets in autoimmunity
46. Novel CD4 and CD8 T-cell subsets
47. Human placental cytotrophoblasts produce the immunosuppressive cytokine interleukin 10
48. Down-regulating effect of IL-4 and IL-10 on the IFN-γ response in atopic dermatitis
49. IL-10: A potential therapy for allergic inflammation?
50. Expression of the t-cell markers CD3, CD4 and CD8 in healthy and atopic children during the first 18 months of life
51. Altered T lymphocyte phenotype at birth in babies born to atopic parents
52. + CD45RA human T cells following polyclonal activation
53. Developmental and maturational changes in human blood lymphocyte subpopulations
54. + cells in the human neonate
55. Stimulation of IgE and IgA production by CD45RA T helper cells in atopic patients
56. In vitro maturation of human neonatal T lymphocytes. II. Cytokines present at priming modulate the development of lymphokine production
57. Prediction of atopic disease in infancy by determination of immunological parameters: IgE, IgE- and IgG-antibodies to food allergens, skin prick tests and T lymphocyte subsets
58. Diagnostic tests in children with atopic dermatitis and food allergy
59. The role of food allergy and mediator release in atopic dermatitis
60. Appearance of IgE antibodies to ingested and inhaled allergens during the first 12 years of life in atopic and non-atopic children
61. Natural history of food allergy
62. Comparison of results of skin tests, RAST, and placebo-controlled food challenges in children with atopic dermatitis
63. Relation between IgG antibodies to foods and IgE antibodies to milk, egg, cat, dog and/or mite in a crosssectional study
64. The development and prediction of atopy in high-risk children: Follow-up at age seven years in a prospective randomized study of combined maternal and infant food allergen avoidance
65. Appearance of atopic disease in relation to serum IgE antibodies in children followed from birth for 4-15 years
66. Prediction of sensitization to inhalant allergens in childhood: Evaluating family history, atopic dermatitis and sensitization to food allergens
67. Prenatal allergen contact with milk proteins
68. Developing patterns of T cell memory to environmental allergens in the first two years of life
69. Fetal peripheral blood mononuclear cell proliferative responses to mitogenic and allergenic stimuli during gestation
70. The effect of maternal and infant exposure to house dust mite and cat allergens on the development of immune responses
71. Prenatal contact with inhalant allergens
72. Maternal influence on IgG subclass antibodies to Bet v 1 during the first 18 months of life as detected with a sensitive ELISA
73. Maternal programming in asthma and allergy
74. Cellular and molecular mechanisms for reduced interleukin-4 and interferon-γ production by neonatal T cells
75. Distribution of th1, th2, and th0 and the Th1/Th2 cell ratios in human peripheral and endometrial T cells
76. Quantitative analysis of peripheral blood Th0, Th1, Th2 and the Th1:Th2 cell ratio during pregnancy and preeclampsia
77. An innate view of human pregnancy
78. Th2-deviation of fetus-specific T cells
79. Neonatal immunity: How well has it grown up?
80. Reduced interferon-gamma (IFN-γ) secretion with increased IFN-γ mRNA expression in atopic dermatitis: Evidence for a post-transcriptional defect
81. Evidence that defective interferon-gamma production in atopic dermatitis patients is due to intrinsic abnormalities
82. Increased levels of IL-13 mRNA, but not IL-4 mRNA, are found in vivo in peripheral blood mononuclear cells (PBMC) of patients with atopic dermatitis (AD)
83. Decreased interferon gamma and increased interleukin-4 production in atopic dermatitis promotes IgE synthesis
84. Reciprocal regulatory effects of IFNgamma and IL-4 on the in vitro development of human Th1 and Th2 clones